HHLR Advisors’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-478,401
| Closed | -$5.51M | – | 63 |
|
|
2023
Q1 | $5.51M | Sell |
478,401
-461,247
| -49% | -$5.31M | 0.1% | 50 |
|
|
2022
Q4 | $10.9M | Sell |
939,648
-60,352
| -6% | -$699K | 0.23% | 37 |
|
|
2022
Q3 | $12.7M | Hold |
1,000,000
| – | – | 0.33% | 33 |
|
|
2022
Q2 | $6.87M | Hold |
1,000,000
| – | – | 0.15% | 40 |
|
|
2022
Q1 | $9.64M | Hold |
1,000,000
| – | – | 0.2% | 35 |
|
|
2021
Q4 | $11.9M | Hold |
1,000,000
| – | – | 0.18% | 45 |
|
|
2021
Q3 | $16.2M | Hold |
1,000,000
| – | – | 0.21% | 49 |
|
|
2021
Q2 | $21M | Hold |
1,000,000
| – | – | 0.22% | 51 |
|
|
2021
Q1 | $15.5M | Buy |
1,000,000
+400,000
| +67% | +$6.21M | 0.15% | 54 |
|
|
2020
Q4 | $12.6M | Hold |
600,000
| – | – | 0.1% | 67 |
|
|
2020
Q3 | $12.1M | Buy |
+600,000
| New | +$12.1M | 0.09% | 59 |
|